Operating Lease, Right-of-Use Asset of iTeos Therapeutics, Inc. from 31 Dec 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
iTeos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Jun 2025.
  • iTeos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $5,129,000, a 6.7% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

iTeos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $5,129,000 -$371,000 -6.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $5,048,000 -$756,000 -13% 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q4 2024 $5,089,000 -$947,000 -16% 31 Dec 2024 10-Q 06 Aug 2025 2025 Q2
Q3 2024 $5,514,000 -$399,000 -6.7% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $5,500,000 +$73,000 +1.3% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,804,000 +$1,202,000 +26% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $6,036,000 +$1,384,000 +30% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $5,913,000 +$1,432,000 +32% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $5,427,000 +$635,000 +13% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $4,602,000 -$632,000 -12% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $4,652,000 -$677,000 -13% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $4,481,000 +$1,622,000 +57% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $4,792,000 +$1,744,000 +57% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $5,234,000 +$2,188,000 +72% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $5,329,000 +$5,329,000 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $2,859,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $3,048,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $3,046,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $0 31 Dec 2020 10-K 23 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.